• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

4.120 +0.080 (+1.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 736,066
Open 4.130
Bid (Size) 4.090 (3,000)
Ask (Size) 4.170 (1,000)
Prev. Close 4.040
Today's Range 3.995 - 4.140
52wk Range 2.860 - 13.99
Shares Outstanding 89,348,107
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Anavex (AVXL) Q1 2026 Earnings Call Transcript ↗
February 09, 2026
Anavex (AVXL) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) Reports Q1 2026 Earnings Beat, Stock Gains in Pre-Market ↗
February 09, 2026
Via Chartmill
Topics Earnings

Performance

YTD
+12.0%
+12.0%
1 Month
-18.1%
-18.1%
3 Month
+30.0%
+30.0%
6 Month
-56.9%
-56.9%
1 Year
-52.8%
-52.8%

More News

Read More
These stocks are moving in today's after hours session ↗
January 13, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
November 10, 2025
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
December 24, 2025
From Schall Law
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
December 17, 2025
From Schall Law
Via GlobeNewswire
News headline image
Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential ↗
December 12, 2025
Via Stocktwits
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
December 10, 2025
From Schall Law
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
December 03, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Anavex (AVXL) Q4 2025 Earnings Call Transcript ↗
November 25, 2025
Via The Motley Fool
Topics Earnings
News headline image
AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug ↗
November 25, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings ↗
November 25, 2025
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
November 19, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign' ↗
November 16, 2025
Via Stocktwits
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
November 14, 2025
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
November 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 14, 2025
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
November 14, 2025
Via Chartmill
News headline image
Discover the top movers in Friday's pre-market session. ↗
November 14, 2025
Via Chartmill
News headline image
Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
November 14, 2025
Via Benzinga
News headline image
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug ↗
November 14, 2025
Via Stocktwits
News headline image
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? ↗
November 14, 2025
Via Stocktwits
News headline image
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group ↗
October 29, 2025
Via Benzinga

Frequently Asked Questions

Is Anavex Life Sciences Corp. - Common Stock publicly traded?
Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.
What exchange does Anavex Life Sciences Corp. - Common Stock trade on?
Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?
The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market
What is the current price of Anavex Life Sciences Corp. - Common Stock?
The current price of Anavex Life Sciences Corp. - Common Stock is 4.120
When was Anavex Life Sciences Corp. - Common Stock last traded?
The last trade of Anavex Life Sciences Corp. - Common Stock was at 02/19/26 04:00 PM ET
What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?
The market capitalization of Anavex Life Sciences Corp. - Common Stock is 368.11M
How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?
Anavex Life Sciences Corp. - Common Stock has 368M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap